Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick N Harter

Showing results (121-130 of 205) with videos related to

Pageof 21
Sort By:
Neuro-Oncology|March 21, 2015
Melanoma brain metastasis is independent of lactate dehydrogenase A expressionTerje Sundstrøm, Heidi Espedal, Patrick N Harter, et al.
Oncology Reports|October 18, 2017
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal diseaseMichael C Burger, Michael W Ronellenfitsch, Nadja I Lorenz, et al.
Journal for Immunotherapy of Cancer|July 20, 2021
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanomaKatharina Filipski, Michael Scherer, Kim N Zeiner, et al.
Neuro-Oncology|December 3, 2015
Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomasPeter Baumgarten, Anna-Eva Blank, Kea Franz, et al.
Neuro-Oncology|July 3, 2021
The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasisCedric Tehranian, Laura Fankhauser, Patrick N Harter, et al.
Neuro-Oncology Advances|March 27, 2026
Disturbance of functional connectivity in patients with low grade glioma is associated with worse progression-free survivalVeit M Stoecklein, Stephan Wunderlich, Jonathan Weller, et al.
Neuropathology and Applied Neurobiology|October 20, 2020
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse gliomaYannick Braun, Katharina Filipski, Simon Bernatz, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2014
Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β-SMAD3 pathway in non-small cell lung adenocarcinomaMaurizio Risolino, Nadia Mandia, Francescopaolo Iavarone, et al.
Clinical and Translational Medicine|November 18, 2024
An AMP-activated protein kinase-PGC-1α axis mediates metabolic plasticity in glioblastomaBenedikt Sauer, Jan Kueckelhaus, Nadja I Lorenz, et al.
Brain Pathology (Zurich, Switzerland)|December 10, 2016
CASP9 germline mutation in a family with multiple brain tumorsMichael W Ronellenfitsch, Ji-Eun Oh, Kaishi Satomi, et al.
Pageof 21

Showing results (121-130 of 205) with videos related to

Sort By:
Pageof 21
Neuro-Oncology|March 21, 2015
Melanoma brain metastasis is independent of lactate dehydrogenase A expressionTerje Sundstrøm, Heidi Espedal, Patrick N Harter, et al.
Oncology Reports|October 18, 2017
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal diseaseMichael C Burger, Michael W Ronellenfitsch, Nadja I Lorenz, et al.
Journal for Immunotherapy of Cancer|July 20, 2021
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanomaKatharina Filipski, Michael Scherer, Kim N Zeiner, et al.
Neuro-Oncology|December 3, 2015
Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomasPeter Baumgarten, Anna-Eva Blank, Kea Franz, et al.
Neuro-Oncology|July 3, 2021
The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasisCedric Tehranian, Laura Fankhauser, Patrick N Harter, et al.
Neuro-Oncology Advances|March 27, 2026
Disturbance of functional connectivity in patients with low grade glioma is associated with worse progression-free survivalVeit M Stoecklein, Stephan Wunderlich, Jonathan Weller, et al.
Neuropathology and Applied Neurobiology|October 20, 2020
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse gliomaYannick Braun, Katharina Filipski, Simon Bernatz, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2014
Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β-SMAD3 pathway in non-small cell lung adenocarcinomaMaurizio Risolino, Nadia Mandia, Francescopaolo Iavarone, et al.
Clinical and Translational Medicine|November 18, 2024
An AMP-activated protein kinase-PGC-1α axis mediates metabolic plasticity in glioblastomaBenedikt Sauer, Jan Kueckelhaus, Nadja I Lorenz, et al.
Brain Pathology (Zurich, Switzerland)|December 10, 2016
CASP9 germline mutation in a family with multiple brain tumorsMichael W Ronellenfitsch, Ji-Eun Oh, Kaishi Satomi, et al.
Pageof 21